Maravai LifeSciences Holdings Management
Management criteria checks 1/4
Maravai LifeSciences Holdings' CEO is Trey Martin, appointed in Jul 2023, has a tenure of less than a year. total yearly compensation is $14.52M, comprised of 4.5% salary and 95.5% bonuses, including company stock and options. directly owns 0.053% of the company’s shares, worth MX$18.99M. The average tenure of the management team and the board of directors is 1.3 years and 3.3 years respectively.
Key information
Trey Martin
Chief executive officer
US$14.5m
Total compensation
| CEO salary percentage | 4.5% |
| CEO tenure | less than a year |
| CEO ownership | 0.05% |
| Management average tenure | 1.3yrs |
| Board average tenure | 3.3yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Dec 31 2023 | n/a | n/a | -US$119m |
| Sep 30 2023 | n/a | n/a | US$25m |
| Jun 30 2023 | n/a | n/a | US$75m |
| Mar 31 2023 | n/a | n/a | US$153m |
| Dec 31 2022 | US$15m | US$660k | US$220m |
Compensation vs Market: Trey's total compensation ($USD14.52M) is above average for companies of similar size in the MX market ($USD756.62K).
Compensation vs Earnings: Insufficient data to compare Trey's compensation with company performance.
CEO
Trey Martin (48 yo)
less than a year
Tenure
US$14,523,493
Compensation
Mr. William E. Martin, III, also known as Trey, was President of Biologics Safety Testing of Maravai LifeSciences Holdings, Inc. since December 5, 2022 until July 27, 2023 and is Chief Executive Officer fr...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Co-Founder & Executive Chairman | 3.3yrs | US$5.48m | 0.052% $ 18.8m | |
| Chief Executive Officer | less than a year | US$14.52m | 0.053% $ 19.0m | |
| Executive VP & CFO | 6.8yrs | US$1.74m | 0.0093% $ 3.3m | |
| Executive VP & Chief Administrative Officer | 1.7yrs | US$3.92m | 0.014% $ 4.9m | |
| Executive Vice President of Biologics Safety Testing | 6.3yrs | US$1.59m | 0.0093% $ 3.4m | |
| Senior Director of Investor Relations | no data | no data | no data | |
| Executive VP | 3.3yrs | US$701.40k | 0.013% $ 4.6m | |
| Executive VP & Chief Commercial Officer | less than a year | no data | 0.0074% $ 2.7m | |
| Chief Innovation Officer | less than a year | no data | no data | |
| Executive Vice President of Enzymes | less than a year | no data | no data | |
| President of Nucleic Acid Production | less than a year | no data | no data |
1.3yrs
Average Tenure
53yo
Average Age
Experienced Management: MRVI *'s management team is not considered experienced ( 1.3 years average tenure), which suggests a new team.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Co-Founder & Executive Chairman | 3.3yrs | US$5.48m | 0.052% $ 18.8m | |
| Director | less than a year | no data | no data | |
| Non-Independent Director | 3.3yrs | US$66.25k | 0.0032% $ 1.2m | |
| Non-Independent Director | 3.3yrs | US$46.88k | 0.0032% $ 1.2m | |
| Independent Director | 3.3yrs | US$45.00k | 0.021% $ 7.4m | |
| Independent Director | 3.3yrs | US$68.75k | 0.024% $ 8.8m | |
| Non-Independent Director | 3.3yrs | US$54.38k | 0.0032% $ 1.2m | |
| Non-Independent Director | 3.3yrs | US$45.00k | 0.0032% $ 1.2m | |
| Independent Director | 3.3yrs | US$46.88k | 0.013% $ 4.6m | |
| Independent Director | 3.3yrs | US$68.75k | 0.047% $ 16.9m | |
| Independent Director | 3.3yrs | US$60.63k | 0.0092% $ 3.3m |
3.3yrs
Average Tenure
58yo
Average Age
Experienced Board: MRVI *'s board of directors are considered experienced (3.3 years average tenure).